Marketing-authorisation holder Β· Canada
Jaapharm Canada Inc.
44 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1β25 of 44
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| JAA PYRAL 125 TABLET 125MG125 mg Β· Tablet | Pyrantel | Canada | Not marketed | 1998 |
| JAA PYRAL 35 TABLET 35MG35 mg Β· Tablet | Pyrantel | Canada | Not marketed | 1989 |
| JAA PYRAL P ORAL PASTE - 125MG/G125 mg / g Β· Paste | Pyrantel | Canada | Not marketed | 1995 |
| JAA PYRAL S SUSPENSION 50MG/7650 mg / ml Β· Suspension | Pyrantel | Canada | Not marketed | 1995 |
| ACE POWDER 1.25GM/227GM1.25 g / 227 g Β· Powder | Acepromazine | Canada | Not marketed | 1991 |
| AMI-NESINE LIQ66.67 mg / ml + 33.33 mg / ml Β· Liquid | Aminophylline, Guaifenesin | Canada | Not marketed | 1996 |
| ASEN 240 BOLUS 15.5GM15.5 g Β· Tablet | Acetylsalicylic acid | Canada | Not marketed | 1996 |
| ASEN POWDER 14.5GM/20GM14.5 g / 20 g Β· Powder | Acetylsalicylic acid | Canada | Not marketed | 1989 |
| BOVIDIGEST15 g / 95 g + 30 g / 95 g + 40 g / 95 g Β· Powder | Acetanilide, Calcium propionate, Sodium propionate | Canada | Not marketed | 1991 |
| BUTASONE 10001000 mg Β· Bolus | Phenylbutazone | Canada | Not marketed | 1999 |
| BUTASONE 400 PWR 100MG/GM100 mg / g Β· Powder | Phenylbutazone | Canada | Not marketed | 1989 |
| BUTASONE CONC PWR 8GM/30GM8 g / 30 g Β· Powder | Phenylbutazone | Canada | Not marketed | 1989 |
| DEXONE10 mg / 15 g Β· Powder | Dexamethasone | Canada | Not marketed | 1989 |
| MEGA B500 mg / 10 ml + 60 mg / 10 ml + 1250 mg / 10 ml + 500 mg / 10 ml + 10000 mcg / 10 ml + 50 mg / 10 ml + 50 mg / 10 ml Β· Powder For Solution | Ascorbic acid, Dexpanthenol, Nicotinamide, Vitamin b1, Vitamin b12, Vitamin b2, Vitamin b6 | Canada | Authorised | |
| SULFA MT66 g / 100 g + 33 g / 100 g Β· Powder | Sulfamethazine, Sulfathiazole | Canada | Not marketed | 2001 |
| T 500200 mg / ml Β· Liquid | Vitamin b1 | Canada | Authorised | |
| TETRA 10001000 mg / g Β· Powder For Solution | Tetracycline | Canada | Not marketed | 1989 |
| TETRA 250250 mg / g Β· Powder For Solution | Tetracycline | Canada | Not marketed | 1993 |
| TETRA 40004 G Β· Bolus | Tetracycline | Canada | Not marketed | 1994 |
| TETRA 5555 mg / g Β· Powder For Solution | Tetracycline | Canada | Not marketed | 1991 |
| TOXILAX1 % / w/w + 0.008 % / w/w + 0.2 % / w/w + 0.2 % / w/w + 1.25 % / w/w + 1 % / w/w + 0.1 % / w/w + 5.25 % / w/w + 54 % / w/w + 25 % / w/w + 10 % / w/w Β· Powder | Calcium phosphate, Ethylenediamine dihydroiodide, Fenugreek, Gentiana lutea, Ginger, Iron oxide, Linseed, Carbonate, Magnesium sulfate, Sodium sulfate, Thiosulfate | Canada | Not marketed | 1999 |
| AMOX 250 CAP 250MG250 mg Β· Capsule | Amoxicillin | Canada | Cancelled | 1991 |
| AMOX 500 CAP 500MG500 mg Β· Capsule | Amoxicillin | Canada | Cancelled | 1991 |
| AMOX S 125 SUS 125MG/5ML125 mg / 5 ml Β· Suspension | Amoxicillin | Canada | Cancelled | 1991 |
| AMOX S 250 SUS 250MG/5ML250 mg / 5 ml Β· Suspension | Amoxicillin | Canada | Cancelled | 1991 |



